IL6 and myeloid sarcoma: Additionally, MS is associated with the parallel upregulation of other proinflammatory cytokines such as interferon-γ (INF-γ), lymphotoxin-α, IL-2, IL-6, IL-12, IL-17, IL-23, IL-33, and downregulation antiinflammatory cytokines such as transforming growth factor-β (TGF-β), IL-4, and IL-10.